- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.02. | The 5 Best Software to Buy for Managing a Spa Franchise | ||
| 27.02. | How an App Store Approach Fuels Innovation and Efficiency in Healthcare | ||
| 27.02. | Building Solid Relationships with Universities Critical for Early Stage Medtech Investors | ||
| 26.02. | Labor Costs and Payer Rates Are Still Squeezing Providers' Margins | ||
| 26.02. | Humana Taps Thyme Care for Value-Based Oncology Care | ||
| 26.02. | The Vibe at ViVE: Health Tech Leaders Share Insights from AI to Value-based Care | ||
| 26.02. | Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma Med in Pivotal Testing | ||
| 26.02. | Radiopharmaceutical Manufacturing: A High-Stakes Race Against Time | ||
| 26.02. | The Role of Medication Delivery in Non-Adherence | ||
| 25.02. | Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023 | ||
| 25.02. | The New Reality of Hospital-Payer Contracts: How Baptist Health Negotiated with Florida Blue | ||
| 25.02. | Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment | ||
| 25.02. | Automating Insurance Verification: A Game-Changer for Pre-Visit Payment Collection | ||
| 25.02. | How to Improve Employee Benefits While Reducing Insurance Costs | ||
| 25.02. | How Expanded Reimbursement for Coronary CTA (CCTA) Could Improve Cardiovascular Outcomes | ||
| 25.02. | The Vibe at ViVE: Health Tech Leaders Discuss Plans for 2025 | ||
| 24.02. | The HRT Club Launches to Expand Access to Hormonal Care | ||
| 24.02. | PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds | ||
| 24.02. | If We Want a More Innovative Healthcare System, Look to Medicaid as a Model | ||
| 24.02. | The Miscalculation of Teletherapy: Why Digital Mental Health Goes Beyond Virtual Sessions | ||
| 24.02. | 'The Hardest Thing Is Separating the Wheat from the Chaff': 5 Leaders on the State of Healthcare AI | ||
| 23.02. | Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe? | ||
| 23.02. | On Heels of FDA Nod, BridgeBio's Rival to Blockbuster Pfizer Drug Wins European Approval | ||
| 23.02. | The Dark Side of AI in Medicare Advantage: When Value-Based Payment Eclipses Value-Based Care | ||
| 23.02. | It's Time for Health Plans to Hold Behavioral Health Providers Accountable for Outcomes |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
